SenesTech Inc. Raises $4.4 Million Through Warrant Exercise; Announces New Private Placement Warrants

Reuters
07-01
SenesTech Inc. Raises $4.4 Million Through Warrant Exercise; Announces New Private Placement Warrants

SenesTech Inc., a leader in fertility control for managing animal pest populations, has announced definitive agreements for the exercise of certain outstanding warrants to purchase a total of 1,458,872 shares of the company's common stock. Originally issued on March 11, 2025, these warrants have an exercise price of $2.90 per share. The transaction is expected to close around July 1, 2025, contingent on customary closing conditions. H.C. Wainwright is acting as the exclusive placement agent for this transaction. As part of the deal, SenesTech will issue new unregistered short-term warrants for up to 1,458,872 shares at an exercise price of $4.15 per share, with a purchase price of $0.125 per warrant in a private placement. These new warrants will be immediately exercisable and expire fifteen months after the effective date of the resale registration statement. The company anticipates gross proceeds of approximately $4.4 million from the existing warrant exercise, before fees and expenses, and potential gross proceeds of $6.0 million if the new warrants are fully exercised. The net proceeds will be used for working capital and general corporate purposes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SenesTech Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: LA21909) on July 01, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10